Zonation and ligand and dose dependence of sphingosine 1-phosphate receptor-1 signalling in blood and lymphatic vasculature

Author:

Del Gaudio Ilaria1ORCID,Nitzsche Anja1ORCID,Boyé Kevin1ORCID,Bonnin Philippe23ORCID,Poulet Mathilde1,Nguyen Toan Q4ORCID,Couty Ludovic1,Ha Hoa T T4ORCID,Nguyen Dat T4,Cazenave-Gassiot Amaury4ORCID,Ben Alaya Khaoula1,Thérond Patrice56,Chun Jerold7,Wenk Markus R4,Proia Richard L8ORCID,Henrion Daniel9ORCID,Nguyen Long N4ORCID,Eichmann Anne110ORCID,Camerer Eric1ORCID

Affiliation:

1. Université Paris Cité, Paris Cardiovascular Research Centre, INSERM U970 , 56 Rue Leblanc, F-75015 Paris , France

2. Physiologie Clinique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Lariboisière , Paris , France

3. Université Paris Cité, INSERM U1144, UFR de Pharmacie , Paris , France

4. Yong Loo Lin School of Medicine, National University of Singapore , Singapore 117596 , Singapore

5. Service de Biochimie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital de Bicêtre, Le Kremlin Bicêtre , France

6. UFR de Pharmacie, EA 4529 , Châtenay-Malabry , France

7. Neuroscience Drug Discovery, Sanford Burnham Prebys Medical Discovery Institute , La Jolla, CA , USA

8. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Institutes of Health , Bethesda, MD , USA

9. MitoVasc Department, Angers University, Team 2 (CarMe), Angers University Hospital (CHU of Angers), CNRS, INSERM U1083 , Angers , France

10. Department of Internal Medicine and Cellular and Molecular Physiology, Yale University School of Medicine , New Haven , USA

Abstract

Abstract Aims Circulating levels of sphingosine 1-phosphate (S1P), an HDL-associated ligand for the endothelial cell (EC) protective S1P receptor-1 (S1PR1), are reduced in disease states associated with endothelial dysfunction. Yet, as S1PR1 has high affinity for S1P and can be activated by ligand-independent mechanisms and EC autonomous S1P production, it is unclear if relative reductions in circulating S1P can cause endothelial dysfunction. It is also unclear how EC S1PR1 insufficiency, whether induced by deficiency in circulating ligand or by S1PR1-directed immunosuppressive therapy, affects different vascular subsets. Methods and results We here fine map the zonation of S1PR1 signalling in the murine blood and lymphatic vasculature, superimpose cell-type–specific and relative deficiencies in S1P production to define ligand source and dose dependence, and correlate receptor engagement to essential functions. In naïve blood vessels, despite broad expression, EC S1PR1 engagement was restricted to resistance-size arteries, lung capillaries, and a subset of high-endothelial venules (HEVs). Similar zonation was observed for albumin extravasation in EC S1PR1-deficient mice, and brain extravasation was reproduced with arterial EC-selective S1pr1 deletion. In lymphatic ECs, S1PR1 engagement was high in collecting vessels and lymph nodes and low in blind-ended capillaries that drain tissue fluids. While EC S1P production sustained S1PR1 signalling in lymphatics and HEV, haematopoietic cells provided ∼90% of plasma S1P and sustained signalling in resistance arteries and lung capillaries. S1PR1 signalling and endothelial function were both surprisingly sensitive to reductions in plasma S1P with apparent saturation around 50% of normal levels. S1PR1 engagement did not depend on sex or age but modestly increased in arteries in hypertension and diabetes. Sphingosine kinase (Sphk)-2 deficiency also increased S1PR1 engagement selectively in arteries, which could be attributed to Sphk1-dependent S1P release from perivascular macrophages. Conclusion This study highlights vessel subtype-specific S1PR1 functions and mechanisms of engagement and supports the relevance of S1P as circulating biomarker for endothelial function.

Funder

French Foundation for Medical Research

French National Research Agency

Singapore Ministry of Health’s National Research Council

Singapore Ministry of Education

Intramural Research Programs of the National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Lefoulon-Delalande Foundation

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3